作者
Leena P Bharath, Barbara S Nikolajczyk
发表日期
2021/5/1
来源
American Journal of Physiology-Cell Physiology
卷号
320
期号
5
页码范围
C873-C879
出版商
American Physiological Society
简介
The biguanide metformin is the most commonly used antidiabetic drug. Recent studies show that metformin not only improves chronic inflammation by improving metabolic parameters but also has a direct anti-inflammatory effect. In light of these findings, it is essential to identify the inflammatory pathways targeted by metformin to develop a comprehensive understanding of the mechanisms of action of this drug. Commonly accepted mechanisms of metformin action include AMPK activation and inhibition of mTOR pathways, which are evaluated in multiple diseases. Additionally, metformin’s action on mitochondrial function and cellular homeostasis processes such as autophagy is of particular interest because of the importance of these mechanisms in maintaining cellular health. Both dysregulated mitochondria and failure of the autophagy pathways, the latter of which impair clearance of dysfunctional, damaged, or …
引用总数
学术搜索中的文章
LP Bharath, BS Nikolajczyk - American Journal of Physiology-Cell Physiology, 2021